https://orcid.org/0000-0001-5610-7606
References
- Ahmed, R. M., Murphy, E., Davagnanam, I., Parton, M., Schott, J. M., Mummery, C. J., … Chataway, J. (2014). A practical approach to diagnosing adult onset leukodystrophies. Journal of Neurology, Neurosurgery & Psychiatry, 85, 770–781. https://doi.org/https://doi.org/10.1136/jnnp-2013-305888
- Ahn, H. J., Chin, J., Park, A., Lee, B. H., Suh, M. K., Seo, S. W., & Na, D. L. (2010). Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): A useful tool for assessing and monitoring cognitive impairments in dementia patients. Journal of Korean Medical Science, 25, 1071–1076. https://doi.org/https://doi.org/10.3346/jkms.2010.25.7.1071
- Han, J., Sarlus, H., Wszolek, Z. K., Karrenbauer, V. D., & Harris, R. A. (2020). Microglial replacement therapy: A potential therapeutic strategy for incurable CSF1R-related leukoencephalopathy. Acta Neuropathologica Communications, 8, 217. https://doi.org/https://doi.org/10.1186/s40478-020-01093-3
- Ikeuchi, T., Mezaki, N., & Miura, T. (2018). Cognitive dysfunction and symptoms of movement disorders in adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Parkinsonism & Related Disorders, 46, S39–s41. https://doi.org/https://doi.org/10.1016/j.parkreldis.2017.08.018
- Konno, T., Tada, M., Tada, M., Koyama, A., Nozaki, H., Harigaya, Y., … Ikeuchi, T. (2014). Haploinsufficiency of CSF-1R and clinicopathologic characterization in patients with HDLS. Neurology, 82, 139–148. https://doi.org/https://doi.org/10.1212/wnl.0000000000000046
- Konno, T., Yoshida, K., Mizuno, T., Kawarai, T., Tada, M., Nozaki, H., … Ikeuchi, T. (2017). Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation. European Journal of Neurology, 24, 37–45. https://doi.org/https://doi.org/10.1111/ene.13125
- Lynch, D. S., Jaunmuktane, Z., Sheerin, U. M., Phadke, R., Brandner, S., Milonas, I., … Houlden, H. (2016). Hereditary leukoencephalopathy with axonal spheroids: A spectrum of phenotypes from CNS vasculitis to parkinsonism in an adult onset leukodystrophy series. Journal of Neurology, Neurosurgery & Psychiatry, 87, 512–519. https://doi.org/https://doi.org/10.1136/jnnp-2015-310788
- Lynch, D. S., Wade, C., Paiva, A. R. B., John, N., Kinsella, J. A., Merwick, A., … Chataway, J. (2019). Practical approach to the diagnosis of adult-onset leukodystrophies: An updated guide in the genomic era. Journal of Neurology, Neurosurgery & Psychiatry, 90, 543–554. https://doi.org/https://doi.org/10.1136/jnnp-2018-319481
- Nicholson, A. M., Baker, M. C., Finch, N. A., Rutherford, N. J., Wider, C., Graff-Radford, N. R., … Rademakers, R. (2013). CSF1R mutations link POLD and HDLS as a single disease entity. Neurology, 80, 1033–1040. https://doi.org/https://doi.org/10.1212/WNL.0b013e31828726a7
- Rademakers, R., Baker, M., Nicholson, A. M., Rutherford, N. J., Finch, N., Soto-Ortolaza, A., … Wszolek, Z. K. (2011). Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nature Genetics, 44, 200–205. https://doi.org/https://doi.org/10.1038/ng.1027
- Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., … Rehm, H. L. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. 17, 405–424. https://doi.org/https://doi.org/10.1038/gim.2015.30
- Schwarz, J. M., Cooper, D. N., Schuelke, M., & Seelow, D. (2014). MutationTaster2: Mutation prediction for the deep-sequencing age. Nature Methods, 11, 361–362. https://doi.org/https://doi.org/10.1038/nmeth.2890
- Sundal, C., Van Gerpen, J. A., Nicholson, A. M., Wider, C., Shuster, E. A., Aasly, J., … Wszolek, Z. K. (2012). MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology, 79, 566–574. https://doi.org/https://doi.org/10.1212/WNL.0b013e318263575a
- Tipton, P. W., Stanley, E. R., Chitu, V., & Wszolek, Z. K. (2021). Is pre-symptomatic immunosuppression protective in csf1r-related leukoencephalopathy? Mov Disord, 36, 852–856. https://doi.org/https://doi.org/10.1002/mds.28515
- Van Gerpen, J. A., Wider, C., Broderick, D. F., Dickson, D. W., Brown, L. A., & Wszolek, Z. K. (2008). Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids. Neurology, 71, 925–929. https://doi.org/https://doi.org/10.1212/01.wnl.0000325916.30701.21